LEPU ScienTech Medical Technology (Shanghai) Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	408.64	325.9	247.67	222.58	148.25	116.45
Revenue Growth (YoY)	41.29%	31.58%	11.27%	50.14%	27.30%	-
Cost of Revenue	40.9	37.09	27.98	25.04	15.13	13.62
Gross Profit	367.75	288.81	219.69	197.55	133.11	102.83
Selling, General & Admin	102.27	92.95	71.91	70.26	29.1	28.33
Research & Development	55.7	61.58	53.87	41.39	38.96	25.83
Other Operating Expenses	-24.78	-24.3	-17.74	-10.78	-5.86	-10.91
Operating Expenses	134.03	124.22	113.72	101.8	61.05	44.87
Operating Income	233.72	164.59	105.97	95.75	72.06	57.96
Interest Expense	-0.19	-0.2	-18.97	-11.55	-0.01	-0.02
Interest & Investment Income	18.74	14.82	5.67	7.85	0.15	0.15
Currency Exchange Gain (Loss)	-2.02	-5.89	-82.28	5.19	-	-
Other Non Operating Income (Expenses)	-1.11	-0.02	-0.05	1.47	-0.48	-0.17
EBT Excluding Unusual Items	249.13	173.29	10.34	98.72	71.73	57.92
Gain (Loss) on Sale of Investments	1.2	-	-4.93	-	-0.14	-
Gain (Loss) on Sale of Assets	-	-	-	-	5.09	2.43
Asset Writedown	-	-	-0	-0	-	-
Other Unusual Items	-	-	-20.44	-32.69	-	-
Pretax Income	250.32	173.29	-15.03	66.03	76.68	60.35
Income Tax Expense	34.13	21.76	4.78	7.33	7.91	8.44
Net Income	216.19	151.53	-19.81	58.7	68.77	51.91
Net Income to Common	216.19	151.53	-19.81	58.7	68.77	51.91
Net Income Growth	586.22%	-	-	-14.65%	32.49%	-
Shares Outstanding (Basic)	347	347	328	304	277	277
Shares Outstanding (Diluted)	347	347	328	304	277	277
Shares Change (YoY)	2.35%	5.86%	7.79%	9.63%	-	-
EPS (Basic)	0.62	0.44	-0.06	0.19	0.25	0.19
EPS (Diluted)	0.62	0.44	-0.06	0.19	0.25	0.19
EPS Growth	570.79%	-	-	-22.14%	32.49%	-
Free Cash Flow	201.85	161.19	52.25	82.83	56.57	51.21
Free Cash Flow Per Share	0.58	0.46	0.16	0.27	0.20	0.18
Dividend Per Share	0.570	0.570	-	-	-	-
Gross Margin	89.99%	88.62%	88.70%	88.75%	89.79%	88.30%
Operating Margin	57.19%	50.50%	42.79%	43.02%	48.61%	49.77%
Profit Margin	52.90%	46.50%	-8.00%	26.37%	46.39%	44.58%
Free Cash Flow Margin	49.40%	49.46%	21.10%	37.21%	38.16%	43.97%
EBITDA	252.6	177.86	117.99	103.88	77.71	62.22
EBITDA Margin	61.81%	54.58%	47.64%	46.67%	52.42%	53.43%
D&A For EBITDA	18.89	13.27	12.02	8.13	5.64	4.26
EBIT	233.72	164.59	105.97	95.75	72.06	57.96
EBIT Margin	57.19%	50.50%	42.79%	43.02%	48.61%	49.77%
Effective Tax Rate	13.64%	12.56%	-	11.10%	10.31%	13.98%

Source: S&P Capital IQ. Standard template. Financial Sources.